Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Unvested Restricted Stock	Common Stock	Additional Paid In Capital	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income (Loss)	Treasury Stock	Common Stock Related to ESOP
Balance at Dec. 31, 2021	$ 179,562			$ 6,570	$ 101,583	$ 75,815		$ (1,222)	$ (68)	$ (3,116)
Net Income (Loss)	27,929					27,929
Other comprehensive (loss) income	(70,342)							(70,342)
Exercise of stock options and warrants	574			30	544
Purchase of treasury shares	(1,365)								(1,365)
Sale of treasury shares	1,134				7				1,127
Restricted stock grants, net of forfeiture			$ (2,074)	66	2,008
Dividends declared	(2,918)					(2,918)
Stock compensation expense	496		344		152
Change for ESOP related shares	(1,044)									(1,044)
Balance at Dec. 31, 2022	$ 134,026	$ (24)	(1,730)	6,666	104,294	100,826	$ (24)	(71,564)	(306)	(4,160)
Accounting Standards Update [Extensible Enumeration]	us-gaap:AccountingStandardsUpdate201911Member	us-gaap:AccountingStandardsUpdate201911Member					us-gaap:AccountingStandardsUpdate201911Member
Net Income (Loss)	$ 26,739					26,739
Other comprehensive (loss) income	7,561							7,561
Exercise of stock options and warrants	354			23	331
Issuance of common stock	32,930			969	31,961
Purchase of treasury shares	(1,080)								(1,080)
Sale of treasury shares	839				(51)				890
Restricted stock grants, net of forfeiture			(392)	12	380
Dividends declared	(3,208)					(3,208)
Stock compensation expense	524		422		102
Change for ESOP related shares	(323)									(323)
Balance at Dec. 31, 2023	$ 198,338		$ (1,700)	$ 7,670	$ 137,017	$ 124,333		$ (64,003)	$ (496)	$ (4,483)